RxDoctor Payments DataLook up a doctor →

Joel Gonzalez, MD

Internal Medicine · Homestead, FLNPI 1902136617

Payments from drug & device makers

$6,240,006in general payments, 2019–2025

Across 431 payments — averaging $14,478 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2.6M
  • Sanofi US Services Inc.$2.2M
  • Sanofi$553K
  • Boehringer Ingelheim$372K
  • Modernatx, Inc.$267K
  • Bausch Health US, LLC$92K
  • plus $165K from 9 others
$1,305in research payments, 2019–2025

Across 7 payments — averaging $186.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1K

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,240,006 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$14,378
Medicare patients
55
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Homestead

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →